Article Text
Editorial
Bone marrow mononuclear cell therapy for acute myocardial infarction: we know what we want, but we just don’t know how yet
Statistics from Altmetric.com
Footnotes
Competing interests KCW has filed a patent application covering the therapeutic use of bone marrow-derived proteins in cardiovascular disease.
Provenance and peer review Commissioned; internally peer reviewed.